参考文献/References:
[1]Punia RP,Mundi I,Arora K,et al.Primary adenocarcinoma of ureter mimicking pyelonephritis.Urol Ann,2010,2(1):42-43.
[2]Gupta P,ALgarwal D,Shruti S,et al.Mucinous adenocarcinoma of renal pelvis in a young male:a diagnostic challenge.Ger Med Sci,2020,18:Doc11.
[3]王桎仙,陈瑞宝,刘畅,等.原发性输尿管腺癌2例报告.泌尿外科杂志(电子版),2016,8(4):59-63.
[4]Abbas M,Kramer MW,Spieker T,et al.Primary mucinous adenocarcinoma of the renal pelvis with carcinoma in situ in the ureter.J Egypt Natl Canc Inst,2014,26(1):51-54.
[5]Sharma V,Miest TS,Juvet TS,et al.The impact of upper tract urothelial carcinoma diagnostic modality on intravesical recurrence after radical nephroureterectomy:a single institution series and updated metaanalysis.J Urol,2021,206(3):558-567.
[6]Roupret M,Babjuk M,Burger M,et al.European Association of Urology Guidelines on upper urinary tract urothelial carcinoma:2020 update.Eur Urol,2021,79(1):62-79.
[7]Nambiyar K,Pandey T,Chatterjee D,et al.Upper urinary tract adenocarcinoma arising in tubular adenoma:a rare entity.Report of 2 cases and review of literature.Int J Surg Pathol,2020,28(3):310-315.
[8]Kato M,Onishi T,Hoshina A,et al.Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen,carbohydrate antigen 19-9 and carbohydrate antigen 125.Urol Int,2010,84(1):116-118.
[9]蔡兴韫,黄吉炜,汪月明,等.原发性上尿路腺癌的诊治分析.中华泌尿外科杂志,2020,41(5):352-355.
[10]刘良,魏东,李守宾,等.原发性输尿管非尿路上皮癌的临床诊治分析.现代泌尿外科杂志，2022,27(2)：148-152.